Sign up to save your podcasts
Or
Share Chronic Hepatitis B in Asian Communities: Overcoming Barriers to Optimize Management
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Chronic Hepatitis B in Asian Communities: Overcoming Barriers to Optimize Management
CME credits: 0.50
Valid until: 10-11-2022
Claim your CME credit at https://reachmd.com/programs/cme/chronic-hepatitis-b-in-asian-communities-overcoming-barriers-to-optimize-management/12495/
Of the approximately 290 million persons living with chronic hepatitis B around the world, about 2 million persons are infected here within the United States. But despite its high prevalence, cultural perceptions and racial disparities can create barriers to diagnosis and care, especially among patients in Asian communities with chronic hepatitis B. That’s why a panel of experts come together in this educational activity to discuss essential prevention, screening, and management options to reduce the number of new cases. They’ll also share strategies for integrating Eastern philosophies with Western approaches to help optimize the management of chronic hepatitis B in the Asian community.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.50
Valid until: 10-11-2022
Claim your CME credit at https://reachmd.com/programs/cme/chronic-hepatitis-b-in-asian-communities-overcoming-barriers-to-optimize-management/12495/
Of the approximately 290 million persons living with chronic hepatitis B around the world, about 2 million persons are infected here within the United States. But despite its high prevalence, cultural perceptions and racial disparities can create barriers to diagnosis and care, especially among patients in Asian communities with chronic hepatitis B. That’s why a panel of experts come together in this educational activity to discuss essential prevention, screening, and management options to reduce the number of new cases. They’ll also share strategies for integrating Eastern philosophies with Western approaches to help optimize the management of chronic hepatitis B in the Asian community.